|
(MoneyNewsWire.Net, May 02, 2018 ) The Middle-East & Africa Genome Editing Market was worth USD 1.13 billion in 2016 and estimated to be growing at a CAGR of 13.98%, to reach USD 2.18 billion by 2021. Genome editing is a technique used to precisely and efficiently modify DNA within a cell using enzymes called engineered nucleases. There are several different types of engineered nucleases in genome editing, all of them having a nuclease part to cut the DNA and a targeting part to recognize where to make the cut. CRISPR-Cas 9 is the most common, cheap and efficient system used for genome editing.
Browse market data tables and in-depth TOC of the MEA Genome Editing Market to 2021 @ https://www.marketdataforecast.com/market-reports/middle-east-and-africa-genome-editing-market-2797/
Gene therapy is a medical technique wherein a new gene is transferred into cells to augment a defective gene. However, gene therapy does not remove or modify the defective DNA and is generally suited only for a limited set of genetically defined diseases. Genome editing, on the other hand, corrects the defective DNA in its native location. The diversity of genetic drivers of disease demands a diversity of solutions. And genome editing has the potential to tackle a variety of types of genome modification to address a broad range of genetically defined diseases.
The key driver of the Genome Editing Market in Middle-East & Africa is the government willingness to fund research and development in the field. The prospects of finding cures for currently incurable diseases and also better health standards and healthcare in general act as drivers for the market. Other than healthcare, genome editing also finds applications in pharmaceutical, agricultural and biotechnological industries. Even though the market holds further development in the coming years, it is brought down to earth by factors such as the high costs associated with the equipment needed for the procedure. As always, ethical concerns are always a concern whenever modification of ‘nature’ is involved. Additionally, the probability of mishaps in modification is another restraint.
Free sample of the report is available @ https://www.marketdataforecast.com/market-reports/middle-east-and-africa-genome-editing-market-2797/request-sample
The Middle-East & Africa Genome Editing market is broadly classified into Cell Line, Animal Genetic and Plant Genetic Engineering in the basis of application, by technology into CRISPR, TALEN, ZFN, Antisense and Other Technologies and on the basis of end user into Biotechnological & Pharmaceutical Companies, Academic and Government Research Institutes and Contract Research Organizations. Based on geography, the Middle-East & Africa market is analysed under Middle-East and Africa. At present, it forms just a small part of the global market share with Middle-East & Africa generating the least revenue. Regions that show promise in the market are Saudi Arabia, Qatar, UAE and South Africa.
The Genome Editing market is highly competitive with a large number of players. Some of the major ones are Thermo Fisher Scientific, Merck KGAA, Horizon Discovery Group Plc, Genscript Biotech Corporation, Sangamo Biosciences, Integrated DNA Technologies, Lonza Group Ltd, New England Biolabs, Origene Technologies, and Transposagen Biopharmaceuticals.
Inquire before buying @ https://www.marketdataforecast.com/market-reports/middle-east-and-africa-genome-editing-market-2797/inquire
The scope of the report provides:
• The evaluation of the current market for your product or services and the future implications of the market
• Addresses the opportunities by better understanding the market through size estimates and growth rate analysis to forecast the market for the future
• Extensive segmentation to understand the dynamics of market at a very granular level by splitting down the market to the smallest segment
• Addresses the key market dynamics involving the drivers, restraints and challenges with an aim of providing insights for gaining market share
• The factors responsible for the shaping of the industry as it is as a result of competitive environment is analyzed through Porter’s Five Forces
• The effects of political, economic, social, technological, legal and environmental factors on the industry is analyzed through PESTLE analysis to better understand the aspects of strategic management required to comply with the exogenous and endogenous factors
• Strategic evaluation of the key players to gain insights of their performance allowing access to their product portfolio, financial performance and the strengths of their business strategic developments
• Comparative study of the firms across the industry measuring their performances based on market share and recent activities in order to achieve competitive intelligence
• Equip you with the information providing with the investment opportunities in the industry
Looking for more? If you are in need of a specific research study, we have an expertise in undertaking a customized study and will aid to meet your research requirement to the fullest.
Order your copy of the report: https://www.marketdataforecast.com/cart/buy-now/middle-east-and-africa-genome-editing-market-2797/
About Us:
Market Data Forecast is a firm working in the area of market research and business intelligence. With rich experience in research across various business domains, we cater to the needs of both individual and corporate clients. Our analyst team comprises expert professionals in market research, who with their collective knowledge and skillset dedicatedly serve clients from various industries and regions.
Contact:
Abhishek Shukla
Sales Manager (International Business Development)
Market Data Forecast
Direct Line: +1-888-702-9626
Mobile: +91 998 555 0206
Mail:abhishek@marketdataforecast.com
Visit MarketDataForecast Blog @ http://www.marketdataforecast.com/blog/
Follow us @ https://in.linkedin.com/company/market-data-forecast
Market Data Forecast.
Abhishek Shukla
+1-888-702-9626
abhishek@marketdataforecast.com
Source: EmailWire.Com 
|
